Building standards of psychedelic care: Qualitative examination of expert perspectives on safety, inclusion, and accountability.
Christina Chwyl, Adrianne R Wilson-Poe, Kim A Hoffman, Alissa Bazinet, Kellie Pertl, Jason B Luoma, Don Des Jarlais, Sarann Bielavitz, P Todd Korthuis
The International journal on drug policy January 1, 2026 DOI: 10.1016/j.drugpo.2025.104938 via PubMed
Summary
AI-generated from the abstractExperts in psychedelic care and harm reduction identified five key areas for improving standards of care: strengthening provider accountability and credibility, advancing culturally responsive and inclusive practices, emphasizing community-based support and integration, ensuring safety through preparation and screening, and navigating legal and informational gray areas. The findings highlight the need for clearer guidelines, robust safety protocols, and accessible support systems to optimize outcomes across diverse populations and settings.
Study at a glance
| Characteristics | Qualitative study Peer reviewed |
|---|---|
| Sample size | 38 |
| Population | U.S. experts with psychedelic content knowledge, including providers (psychiatrists, clinical psychologists, addiction medicine experts, licensed/unlicensed practitioners) and harm reduction specialists |
| Topics | Psilocybin |
| Keywords | Harm reduction Psychedelics Qualitative research Standards of care |
| Citations | 3 |
| Key finding | Five themes emerged for improving psychedelic care: strengthening accountability, advancing cultural inclusivity, supporting community integration, ensuring safety protocols, and navigating legal gray areas. |
Abstract
There remain significant gaps in knowledge about best practices for facilitated psychedelic care and psychedelic-assisted therapy. To inform the development of service models that support safe and beneficial experiences, this qualitative study explored expert perspectives on current and ideal standards of care, including key practices (e.g., screening, adapting care to diverse contexts) and regulatory and research challenges that influence service delivery. Online focus groups (n = 8) were conducted with a purposive U.S. sample of people with psychedelic content knowledge expertise, including providers (psychiatrists, clinical psychologists, addiction medicine experts, and licensed/unlicensed practitioners) and harm reduction specialists. Transcripts were analyzed through Thematic Analysis team-based coding using a combined inductive-deductive approach within a semantic framework. Participants (N = 38, mean age 47 (SD = 10) years, 53 % women, 84 % white) had an average of 10 years of psychedelic service experience (SD = 11) across diverse settings, including festivals/events, service centers, and clinical, research, ceremonial, community and 'underground' contexts. Five key themes emerged: (1) 'Strengthening Safety through Credibility and Accountability'; (2) 'Advancing Culturally Responsive and Inclusive Psychedelic Care'; (3) 'Healing in Community: The Crucial Role of Ongoing Support and Integration'; (4) 'Ensuring Safe Psychedelic Use: Preparation, Screening, Vulnerability, and Medication Management'; and (5) 'Providing Informed Guidance and Navigating Legal and Informational Gray Areas.' Overall, results underscore the need for stronger provider accountability structures, culturally inclusive practices, accessible and integrated community support, robust safety and screening protocols, and clearer guidelines to help providers navigate legal complexities, ensure safety, and optimize outcomes across diverse populations.